https://www.avient.com/company/sustainability/planet
Global ISO Certificate Library
https://www.avient.com/company/sustainability/performance
Global ISO Certificate Library
https://www.avient.com/company/policies-and-governance/candidate-privacy-notice
Global ISO Certificate Library
https://www.avient.com/news/‘future-proof’-pharma-packaging-avient-launches-new-regulatory-compliant-mevopur-amber-masterbatches
Produced under rigorous cGMP and medical manufacturing protocols, the new amber color concentrates are made in three dedicated EN ISO 13485-2016 registered facilities using only medical-grade ingredients.
They are formulated without animal-derived substances and phthalates, and have been pre-tested for compliance with:
• ISO 10993-1 and USP parts , (including class VI)
• European Pharmacopoeia, monograph 3.1.15
• USP and
• elemental analysis, as per ICH Q3D
To access Avient’s news library online, please visit www.avient.com/news.
https://www.avient.com/news/avient-feature-specialty-technologies-and-services-healthcare-mdm-west-2023
Manufactured across a global network of ISO 13485 facilities, they meet or exceed requirements for regulations such as USP Class VI, ISO 10993, USP 661, and ICH Q3D.
Like other Mevopur formulations, they are manufactured in dedicated ISO 13485 facilities and supported by testing to ISO 10993-1, USP, European Pharmacopeia, and ICH Q3D guidelines.
To access Avient’s news library online, please visit www.avient.com/news.
https://www.avient.com/company/policies-and-governance/global-policy-antitrust
Global ISO Certificate Library
https://www.avient.com/company/policies-and-governance-0/code-conduct
Global ISO Certificate Library
https://www.avient.com/company/purpose-strategic-framework
Global ISO Certificate Library
https://www.avient.com/company/sustainability/sustainability-report/products/no-surprises-pledge-0
Global ISO Certificate Library
https://www.avient.com/company/sustainability/performance/report-archive
Global ISO Certificate Library